Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MUZHU MINING LTD | Y33 | May 31, 2024 | 0.03 | 0.00 |
MVB Financial Corp. | MV6 | May 31, 2024 | 16.60 | +3.11 |
Mvise AG | C1V | May 31, 2024 | 0.61 | 0.00 |
MVV Energie AG | MVV1 | May 31, 2024 | 30.40 | -0.65 |
MWB FAIRTRADE WPHDL.NA ON | MWB0 | May 31, 2024 | 3.90 | -7.14 |
Mycronic | MLT | May 31, 2024 | 35.12 | -0.73 |
Mydecine Innovations Group Inc | 0NF0 | May 31, 2024 | 0.01 | -4.76 |
Myer Holdings Ltd | 30M | May 31, 2024 | 0.37 | +0.54 |
Myers Industries, Inc. | MJF | May 31, 2024 | 14.50 | +3.57 |
MYHEALTHCHECKED LS -,015 | 0I10 | May 31, 2024 | 0.12 | +10.81 |
MYHOTELMATCH EO 1,- | 6GD0 | May 31, 2024 | 0.84 | 0.00 |
Mynaric ADR | M0YA | May 31, 2024 | 4.00 | +1.01 |
MYNARIC AG NA O.N. | M0YN | May 31, 2024 | 16.80 | +1.51 |
Mynd.Ai | WK6 | May 31, 2024 | 2.32 | -3.33 |
Myomo Inc. | 0M61 | May 31, 2024 | 3.15 | +0.16 |
MYR Group, Inc. | MYP | May 31, 2024 | 145.00 | +0.69 |
Myriad Genetics, Inc. | MYD | May 31, 2024 | 20.60 | -0.96 |
MYRIAD URANIUM CORP. | C3Q | May 31, 2024 | 0.19 | +0.54 |
Mytilineos S.A. | MYH | May 31, 2024 | 36.92 | +0.54 |
N Brown Group PLC | BGUA | May 31, 2024 | 0.13 | -0.79 |
N4 Pharma plc. | 0GO | May 31, 2024 | 0.00 | 0.00 |
NaaS Technology ADR | 6RE0 | May 31, 2024 | 0.32 | +1.91 |
Nabaltec AG | NTG | May 31, 2024 | 16.65 | +0.91 |
Nabors Industries Ltd | NBI1 | May 31, 2024 | 65.50 | -0.76 |
Nabtesco Corp. | 3N8 | May 31, 2024 | 15.40 | +3.36 |
Nachi-Fujikoshi Corp. | 8UM | May 31, 2024 | 20.20 | +3.06 |
Nacon S.A. | 4AW | May 31, 2024 | 1.24 | +1.14 |
Nafco Co | 64E | May 31, 2024 | 16.90 | +1.81 |
NAGACORP | N9J | May 31, 2024 | 0.46 | -0.33 |
Nagambie Resources Limited | P6C | May 31, 2024 | 0.00 | -50.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.